Avaxim stock shortage
The manufacturer of Avaxim®, a hepatitis A vaccine, has written to healthcare professionals advising of a global shortage of this product.
The supply issues are as a result of a manufacturing problem and the manufacturer is currently unable to meet any orders.
Action: Clinicians should be aware of this shortage and seek an alternative supplier if affected.
| « Implanon failure rate | CKS Update - January 2011 » |
